What to say and how to say it: effective communication for cardiovascular disease prevention.
Curr Opin Cardiol
; 31(5): 537-44, 2016 09.
Article
em En
| MEDLINE
| ID: mdl-27428113
ABSTRACT
PURPOSE OF REVIEW Current guidelines for cholesterol treatment emphasize the importance of engaging patients in a risk-benefit discussion prior to initiating statin therapy. RECENT FINDINGS:
Although current risk prediction algorithms are well defined, there is less data on how to communicate with patients about cardiovascular disease risk, benefits of treatment, and possible adverse effects.SUMMARY:
We propose a four-part model for effective shared decision-making 1) Assessing patient priorities, perceived risk, and prior experience with cardiovascular risk reduction; 2) Arriving at a recommendation for therapy based on the patient's risk of disease, guideline recommendations, new clinical trial data, and patient preferences; 3) Communicating this recommendation along with risks, benefits, and alternatives to therapy following best practices for discussing numeric risk; and 4) Arriving at a shared decision with the patient with ongoing reassessment as risk factors and patient priorities change.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Participação do Paciente
/
Relações Médico-Paciente
/
Doenças Cardiovasculares
/
Comunicação
/
Inibidores de Hidroximetilglutaril-CoA Redutases
/
Tomada de Decisões
/
Tomada de Decisão Clínica
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Qualitative_research
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article